Sunday, November 17, 2024
HomeTagsRetinal vein occlusion

retinal vein occlusion

FDA Approves Genentech’s Vabysmo Prefilled Syringe (PFS) for Three Leading Causes of Vision Loss

Genentech, a member of the Roche Group announced the U.S. Food and Drug Administration (FDA) has approved the Vabysmo (faricimab-svoa) 6.0 mg single-dose prefilled...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics